PGGM Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-78,907
Closed -$1.86M 390
2023
Q1
$1.86M Hold
78,907
0.03% 310
2022
Q4
$2.2M Buy
78,907
+3,792
+5% +$97K 0.04% 277
2022
Q3
$1.76M Buy
+75,115
New +$2.27M 0.03% 304
2022
Q1
$1.45M Hold
47,554
0.01% 342
2021
Q4
$1.45M Sell
47,554
-122,021
-72% -$3.97M 0.01% 342
2021
Q3
$5.56M Buy
169,575
+34,424
+25% +$1.1M 0.03% 302
2021
Q2
$4.09M Buy
+135,151
New +$4.45M 0.02% 311

Other funds holding OGN

PGGM Investments's OGN Position: Q2 2023 in Review

PGGM Investments sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 78,907 shares — an estimated $1.86M sold.

PGGM Investments first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $5.56M in Q3 2021. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • PGGM Investments reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • PGGM Investments sold 78,907 Organon & Co shares in Q2 2023, an estimated $1.86M.
  • PGGM Investments first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • PGGM Investments's Organon & Co position peaked at $5.56M in Q3 2021.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on PGGM Investments's 13F filing for Q2 2023, filed 7 Aug 2023.